Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 9/2014

01-09-2014 | Original Paper

Risk Compensation Following Male Circumcision: Results from a Two-Year Prospective Cohort Study of Recently Circumcised and Uncircumcised Men in Nyanza Province, Kenya

Authors: Nelli Westercamp, Kawango Agot, Walter Jaoko, Robert C. Bailey

Published in: AIDS and Behavior | Issue 9/2014

Login to get access

Abstract

We present the results of the first study of longitudinal change in HIV-associated risk behaviors in men before and after circumcision in the context of a population-level voluntary medical male circumcision (VMMC) program. The behaviors of 1,588 newly circumcised men and 1,598 age-matched uncircumcised controls were assessed at baseline, 6, 12, 18 and 24 months of follow-up. Despite the precipitous decline in perception of high HIV risk among circumcised men (30–14 vs. 24–21 % in controls) and increased sexual activity among the youngest participants (18–24 years; p-time < 0.0001, p-group = 0.96), all specific risk behaviors decreased over time similarly in both groups. The proportion of men reporting condom use at last sex increased for both groups, with a greater increase among circumcised men (30 vs. 6 %). We found no evidence of risk compensation in men following circumcision. Concerns about risk compensation should not impede the widespread scale-up of VMMC initiatives.
Literature
1.
Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56.PubMedCrossRef
2.
Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66.PubMedCrossRef
3.
Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):298.CrossRef
4.
5.
Weiss HA, Dickson KE, Agot K, Hankins CA. Male circumcision for HIV prevention: current research and programmatic issues. AIDS (Lond, Engl). 2010;24(Suppl 4):61–9.CrossRef
6.
Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006;3(12):517.CrossRef
7.
Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007;11(3):341–55.PubMedCentralPubMedCrossRef
8.
9.
Gray RH, Li X, Kigozi G, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS (Lond, Engl). 2007;21(7):845–50.CrossRef
10.
Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007;7:16.PubMedCentralPubMedCrossRef
11.
UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009;6(9):1000109.CrossRef
12.
Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med. 2006;3(7):262.CrossRef
13.
de Bruyn G, Martinson NA, Gray GE. Male circumcision for HIV prevention: developments from sub-Saharan Africa. Expert Rev Anti-infect Therapy. 2010;8(1):23–31.CrossRef
14.
Hankins C, Forsythe S, Njeuhmeli E. Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med. 2011;8(11):1001127.CrossRef
15.
World Health Organization (WHO). Progress in scaling up voluntary medical male circumcision for HIV prevention in east and southern Africa: January–December. Geneva: World Health Organization; 2011. p. 2012.
16.
Hogben M, Liddon N. Disinhibition and risk compensation: scope, definitions, and perspective. Sex Transm Dis. 2008;35(12):1009–10.PubMed
17.
Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ (Clin Res Ed). 2006;332(7541):605–7.CrossRef
18.
Kalichman S, Eaton L, Pinkerton S. Circumcision for HIV prevention: failure to fully account for behavioral risk compensation. PLoS Med. 2007;4(3):138.CrossRef
19.
White RG, Glynn JR, Orroth KK, et al. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (Lond, Engl). 2008;22(14):1841–50.CrossRef
20.
Alsallaq RA, Cash B, Weiss HA, et al. Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. Epidemics. 2009;1(3):139–52.PubMedCrossRef
21.
Andersson KM, Owens DK, Paltiel AD. Scaling up circumcision programs in southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission. AIDS Behav. 2011;15(5):938–48.PubMedCentralPubMedCrossRef
22.
Dushoff J, Patocs A, Shi CF. Modeling the population-level effects of male circumcision as an HIV-preventive measure: a gendered perspective. PLoS One. 2011;6(12):28608.CrossRef
23.
Hallett TB, Alsallaq RA, Baeten JM, et al. Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect. 2011;87(2):88–93.PubMedCentralPubMedCrossRef
24.
Hallett TB, Singh K, Smith JA, et al. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One. 2008;3(5):2212.CrossRef
25.
Njeuhmeli E, Forsythe S, Reed J, et al. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011;8(11):1001132.CrossRef
26.
Agot KE, Kiarie JN, Nguyen HQ, et al. Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J AIDS. 2007;44(1):66–70.
27.
Kong X, Kigozi G, Nalugoda F, et al. Assessment of changes in risk behaviors during 3 years of posttrial follow-up of male circumcision trial participants uncircumcised at trial closure in Rakai, Uganda. Am J Epidemiol. 2012;176(10):875–85.PubMedCentralPubMedCrossRef
28.
Mattson CL, Campbell RT, Bailey RC, et al. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One. 2008;3(6):2443.CrossRef
29.
Gray R, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS (Lond, Engl). 2012;26(5):609–15.CrossRef
30.
Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (Online). 2009;2:CD003362.
31.
World Health Organization (WHO). Progress in scale-up of male circumcision for HIV prevention in Eastern and Southern Africa : focus on service delivery. Geneva, Switzerland: World Health Organization, 2011.
32.
NACC and NASCOP. Kenya AIDS epidemic update 2011. Nairobi, Kenya: 2012.
33.
Progress in voluntary medical male circumcision service provision. Kenya, 2008–2011. MMWR Morb Mortal Wkly Rep. 2012;61(47):957–61.
34.
Westercamp M, Agot K, Bailey RC. Population-level changes over two years of a voluntary medical male circumcision program in Kisumu, Kenya: circumcision prevalence, beliefs, and HIV risk behaviors. Ethiopia: ICASA; Addis Ababa; 2011.
35.
Westercamp M, Bailey RC, Bukusi EA, et al. Male circumcision in the general population of Kisumu, Kenya: beliefs about protection, risk behaviors, HIV, and STIs. PLoS One. 2010;5(12):15552.CrossRef
36.
Hedeker D, Gibbons RD, Waternaux C. Sample size estimation for longitudinal designs with attrition: comparing time-related contrasts between two groups. J Educ Behav Stat. 1999;24(1):70–93.CrossRef
37.
Hedeker D, Barlas S. RMASS2: Repeated measures with attrition: sample sizes for 2 groups. Chicago: University of Illinois at Chicago, Division of Epidemiology & Biostatistics; 1999.
38.
SAS Institute Inc. SAS software. Version 9.1.3 ed. Cary, NC; 2008.
39.
Kalichman SC, Eaton L, Pinkerton SD. Male circumcision in HIV prevention. Lancet. 2007;369(9573):1597.PubMedCrossRef
40.
Mad rush to be circumcised. Standard, Kenya; 2008.
41.
Milford C, Smit JA, Beksinska ME, Ramkissoon A. “There’s evidence that this really works and anything that works is good”: views on the introduction of medical male circumcision for HIV prevention in South Africa. AIDS Care. 2012;24(4):496–501.PubMed
42.
Reed JB, Njeuhmeli E, Thomas AG, et al. Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J AIDS. 2012;15(60):S88–95.
43.
AIDS Vaccine Advocacy Coalition. A new way to protect against HIV? Understanding the results of male circumcision studies for HIV prevention. NewYork: AVAC; 2007.
44.
Bailey RC, Muga R, Poulussen R, Abicht H. The acceptability of male circumcision to reduce HIV infections in Nyanza Province, Kenya. AIDS Care. 2002;14(1):27–40.PubMedCrossRef
45.
Kelly A, Kupul M, Fitzgerald L, et al. “Now we are in a different time; various bad diseases have come.” Understanding men’s acceptability of male circumcision for HIV prevention in a moderate prevalence setting. BMC Public Health. 2012;12:67.PubMedCentralPubMedCrossRef
46.
Ngalande R, Levy J, Kapondo C, Bailey RC. Acceptability of male circumcision for prevention of HIV infection in Malawi. AIDS Behav. 2006;10(4):377–85.PubMedCrossRef
47.
Rain-Taljaard RC, Lagarde E, Taljaard DJ, et al. Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection. AIDS Care. 2003;15(3):315–27.PubMedCrossRef
48.
Alsallaq RA, Abu-Raddad L. Male circumcision is a leading factor behind the differential HIV prevalence in Sub-Saharan Africa (Abstract no. MOPE0254). AIDS 2008—XVII International AIDS Conference; 2008.
49.
Crosby RA, Ricks J, Young A. Condom migration resulting from circumcision, microbicides and vaccines: brief review and methodological considerations. Sex Health. 2012;9(1):96–102.PubMedCrossRef
50.
Hankins C. Male circumcision: implications for women as sexual partners and parents. Reprod Health Matters. 2007;15(29):62–7.PubMedCrossRef
51.
Riess TH, Achieng MM, Otieno S, Ndinya-Achola JO, Bailey RC. “When I was circumcised I was taught certain things”: risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya. PLoS One. 2010;5(8):12366.CrossRef
52.
Agot KE, Ndinya-Achola JO, Kreiss JK, Weiss NS. Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology. 2004;15(2):157–63.PubMedCrossRef
53.
Republic of Kenya Ministry of Public Health & Sanitation. National strategy for voluntary medical male circumcision. National AIDS & STD Control Programme (NASCOP), Nairobi; 2009.
54.
National AIDS and STI Control Programme. Kenya AIDS Indicator Survey (KAIS) 2007: preliminary report. Nairobi: Ministry of Health; 2008.
55.
Fonner VA, Denison J, Kennedy CE, O’Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev (Online). 2012;9:CD001224.
56.
Festinger L. A theory of cognitive dissonance. Stanford, California: Stanford University Press; 1962.
57.
Grund JM, Hennink MM. A qualitative study of sexual behavior change and risk compensation following adult male circumcision in urban Swaziland. AIDS Care. 2012;24(2):245–51.PubMed
58.
Langhaug LF, Sherr L, Cowan FM. How to improve the validity of sexual behaviour reporting: systematic review of questionnaire delivery modes in developing countries. Trop Med Int Health (TM IH). 2010;15(3):362–81.CrossRef
59.
Mensch BS, Hewett PC, Erulkar AS. The reporting of sensitive behavior by adolescents: a methodological experiment in Kenya. Demography. 2003;40(2):247–68.PubMedCrossRef
60.
Phillips AE, Gomez GB, Boily MC, Garnett GP. A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. Int J Epidemiol. 2010;39(6):1541–55.PubMedCrossRef
61.
Vu LT, Nadol P, Le LC. HIV-Related Risk Behaviors Among the General Population: A Survey Using Audio Computer-Assisted Self-Interview in 3 Cities in Vietnam. Asia-Pac j pub health/Asia-Pac Academic Consort Pub Health. 2012.
Metadata
Title
Risk Compensation Following Male Circumcision: Results from a Two-Year Prospective Cohort Study of Recently Circumcised and Uncircumcised Men in Nyanza Province, Kenya
Authors
Nelli Westercamp
Kawango Agot
Walter Jaoko
Robert C. Bailey
Publication date
01-09-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0846-4

Other articles of this Issue 9/2014

AIDS and Behavior 9/2014 Go to the issue

Original Paper

Adherence to Rectal Gel Use Among Mainly Ethnic Minority Young Men Who have Sex with Men During A 3-Month Placebo Gel Trial: Implications for Microbicide Research

Original Paper

Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study)

Original Paper

Use of Geosocial Networking (GSN) Mobile Phone Applications to Find Men for Sex by Men Who Have Sex with Men (MSM) in Washington, DC

Original Paper

Positive Choices: Outcomes of a Brief Risk Reduction Intervention for Newly HIV-Diagnosed Men Who Have Sex with Men

Original Paper

Drug Users’ Willingness to Encourage Social, Sexual, and Drug Network Members to Receive an HIV Vaccine: A Social Network Analysis

Original Paper

Tensions Between the Epidemiology and Psychology of HIV Risk: Implications for Pre-exposure Prophylaxis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits